Provided by Tiger Trade Technology Pte. Ltd.

Vir Biotechnology, Inc.

10.81
-0.3700-3.31%
Pre-market: 10.880.0700+0.65%04:03 EDT
Volume:1.95M
Turnover:21.17M
Market Cap:1.82B
PE:-6.37
High:11.38
Open:11.04
Low:10.74
Close:11.18
52wk High:11.94
52wk Low:4.75
Shares:168.65M
Float Shares:130.00M
Volume Ratio:0.87
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6972
EPS(LYR):-3.1619
ROE:-26.08%
ROA:-14.51%
PB:1.86
PE(LYR):-3.42

Loading ...

Apr 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Major Issues Report

Form 8-K - Current report
Mar 03, 2026

Proposed Sale Of Securities

Form 144 | VIR BIO's Director Vicki Lee Sato proposes to sell 88,000 shares, with a total value of approximately $799,920.
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 25, 2026

Proposed Sale Of Securities

Form 144 | Vir Biotechnology Stockholder SVF Endurance (Cayman) Limited proposes to sell 400,000 Shares, with a total value of approximately $3.80 Million.
Feb 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 23, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2026

Major Issues Report

Form 8-K - Current report
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities